Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Twist Bioscience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3447
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single variant libraries, clonal perfect genes and non-clonal fragments, among others. The company operates in the US, Europe, Israel, and Singapore. Twist Bioscience is headquartered in San Francisco, California, the US.

Twist Bioscience Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Partnerships 23
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Equity Offering 26
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp – Key Competitors 27
Twist Bioscience Corp – Key Employees 28
Twist Bioscience Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Feb 28, 2018: Twist Bioscience Expands North American Presence With Office in San Diego, California 30
Corporate Communications 31
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 31
Government and Public Interest 32
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 32
Product News 33
Jun 18, 2018: Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering 33
Feb 14, 2018: Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing 34
Other Significant Developments 35
Jul 11, 2017: Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp, Key Competitors 27
Twist Bioscience Corp, Key Employees 28
Twist Bioscience Corp, Subsidiaries 29

List of Figures
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Living Cell Technologies Ltd (LCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • Fifth Street Finance Corp.:企業のM&A・事業提携・投資動向
    Fifth Street Finance Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fifth Street Finance Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Teachers Mutual Bank Ltd:企業の戦略的SWOT分析
    Teachers Mutual Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • DHL Supply Chain:企業の戦略・SWOT・財務分析
    DHL Supply Chain - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Delphi Genetics SA-製薬・医療分野:企業M&A・提携分析
    Summary Delphi Genetics SA (Delphi Genetics) is a genetic engineering and bioproductions company that develops products and technologies for gene cloning and protein expression in bacteria. The company offers services which include gene synthesis, DNA cloning and mutagenesis Plasmid production, prot …
  • North Energy ASA (NORTH):企業の財務・戦略的SWOT分析
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that provides exploration and development services in Norwegian Continental Shelf (NCS). The company’s services include oil and gas exploration and development, license mapping and drilling programs, and conducting geological …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oral Health Products, Inc.:企業の戦略・SWOT・財務情報
    Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AusTex Oil Ltd:企業の戦略的SWOT分析
    AusTex Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務分析
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sushico:企業の戦略・SWOT・財務分析
    Sushico - Strategy, SWOT and Corporate Finance Report Summary Sushico - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Sunflower Electric Power Corporation:企業の戦略的SWOT分析
    Sunflower Electric Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務情報
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Grant Thornton International Ltd.:企業の戦略・SWOT・財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ACEA Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary ACEA Biosciences Inc (ACEA) is a biotechnology company that concentrates on the development and commercialization of innovative cell analysis instrumentation for life science research and clinical diagnostics. The company's products include impedance-based, label-free, and real-time cell ana …
  • Aeras Global TB Vaccine Foundation Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aeras Global TB Vaccine Foundation Inc (Aeras) is a nonprofit biotechnology organization that develops tuberculosis (TB) vaccines. The organization provides TB vaccine candidates, preclinical candidates and vaccine candidates. It offers services such as portfolio management, preclinical rese …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆